(19)
(11) EP 1 598 341 A8

(12) CORRECTED EUROPEAN PATENT APPLICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 A1)

(48) Corrigendum issued on:
01.03.2006 Bulletin 2006/09

(43) Date of publication:
23.11.2005 Bulletin 2005/47

(21) Application number: 04012153.5

(22) Date of filing: 21.05.2004
(51) International Patent Classification (IPC): 
C07D 217/14(1985.01)
A61K 31/472(2000.01)
 C07D 217/16(1985.01)
A61P 3/10(2000.01)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
Designated Extension States:
AL HR LT LV MK

(71) Applicant: Santhera Pharmaceuticals (Deutschland) Aktiengesellschaft
69120 Heidelberg (DE)

(72) Inventors:
  • Edwards, Paul John
    69115 Heidelberg (DE)
  • Cerezo-Galvez, Silvia
    42287 Wuppertal (DE)
  • Feurer, Achim
    69259 Wilhelmsfeld (DE)
  • Matassa, Victor Giulio
    69493 Hirschberg (DE)
  • Nordhoff, Sonja
    69198 Schriesheim (DE)
  • Rummey, Christian
    69221 Dossenheim (DE)

(74) Representative: Grünecker, Kinkeldey, Stockmair & Schwanhäusser Anwaltssozietät 
Maximilianstrasse 58
80538 München
80538 München (DE)

   


(54) DPP-IV inhibitors


(57) The invention relates to compounds of formula (I)

wherein Z, R1-8, n, A1, X1 and X2 have the meaning as cited in the description and the claims. Said compounds are useful as DPP-IV inhibitors. The invention also relates to the preparation of such compounds as well as the production and use thereof as medicament.